Your browser doesn't support javascript.
loading
[Analysis on the consciousness of the early cancer treatment and its influencing factors among urban residents in China from 2015 to 2017].
Li, H C; Wang, K; Yuan, Y N; Mao, A Y; Liu, C C; Liu, S; Yang, L; Huang, H Y; Dong, P; Wang, D B; Liu, G X; Liao, X Z; Bai, Y N; Sun, X J; Ren, J S; Yang, L; Wei, D H; Song, B B; Lei, H K; Liu, Y Q; Zhang, Y Z; Ren, S Y; Zhou, J Y; Wang, J L; Gong, J Y; Yu, L Z; Liu, Y Y; Zhu, L; Guo, L W; Wang, Y Q; He, Y T; Lou, P A; Cai, B; Sun, X H; Wu, S L; Qi, X; Zhang, K; Li, N; Dai, M; Chen, W Q; Wang, N; Qiu, W Q; Shi, J F.
Afiliação
  • Li HC; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Wang K; Department of Public Health Strategy Research, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China.
  • Yuan YN; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Mao AY; Department of Public Health Strategy Research, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China.
  • Liu CC; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Liu S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Yang L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Huang HY; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Dong P; Department of Public Health Strategy Research, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China.
  • Wang DB; Health Management College, Anhui Medical University, Hefei 230032, China.
  • Liu GX; School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Liao XZ; The Department of Cancer Prevention and Control, Hunan Provincial Cancer Hospital, Changsha 410006, China.
  • Bai YN; School of Public Health, Lanzhou University, Lanzhou 730000, China.
  • Sun XJ; School of Health Care Management, Shandong University, Jinan 250012, China.
  • Ren JS; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Yang L; School of Public Health, Guangxi Medical University, Nanning 530021, China.
  • Wei DH; Department of Medical Examination for Cancer Prevention, Anhui Provincial Cancer Hospital, Hefei 230032, China.
  • Song BB; The Department of Cancer Prevention and Control, Affiliated Cancer Hospital of Harbin Medical University, Harbin 150081, China.
  • Lei HK; Department of Cancer Research and Control, Chongqing University Cancer Hospital/Chongqing Cancer Institute/Chongqing Cancer Hospital, Chongqing 400030, China.
  • Liu YQ; Department of Cancer Epidemiology, Gansu Provincial Cancer Hospital, Lanzhou 730050, China.
  • Zhang YZ; Department of Epidemiology, Shanxi Provincial Center Hospital, Taiyuan 030013, China.
  • Ren SY; Institute for Chronic and Non-communicable Disease Prevention and Control, Yunnan Center for Disease Prevention and Control, Kunming 650118, China.
  • Zhou JY; Department of Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Wang JL; The Department of Cancer Prevention and Control, Shandong Tumor Hospital, Jinan 250117, China.
  • Gong JY; The Department of Cancer Prevention and Control, Shandong Tumor Hospital, Jinan 250117, China.
  • Yu LZ; Institute for Chronic and Non-communicable Disease Prevention and Control, Liaoning Provincial Center for Disease Control and Prevention, Shenyang 110005, China.
  • Liu YY; The Department of Cancer Prevention and Control, Liaoning Cancer Hospital & Institute, Shenyang 110042, China.
  • Zhu L; Cancer Research Institute, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830011, China.
  • Guo LW; Office for Cancer Control and Research, Henan Cancer Hospital/The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
  • Wang YQ; Department of Cancer Prevention, Cancer hospital of University of Chinese Academy of Sciences/Zhejiang cancer hospital, Hangzhou 310022, China.
  • He YT; The Department of Cancer Prevention and Control, Cancer Institute, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang 050011, China.
  • Lou PA; Department of Control and Prevention of Chronic Non-communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, China.
  • Cai B; Department of Health Education and Chronic Disease Control, Nantong Center for Disease Control and Prevention, Nantong 226000, China.
  • Sun XH; Endocrine Department, Ningbo NO.2 Hospital, Ningbo 315010, China.
  • Wu SL; Department of Cardiovascular Diseases, Kailuan General Hospital, Tangshan 063000, China.
  • Qi X; Officeof Cancer Screening, Tangshan People's Hospital, Tangshan 063001, China.
  • Zhang K; Department of Medical Examination for Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Li N; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Dai M; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Chen WQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Wang N; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Qiu WQ; Department of Public Health Strategy Research, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing 100020, China.
  • Shi JF; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 54(1): 69-75, 2020 Jan 06.
Article em Zh | MEDLINE | ID: mdl-31914572
Objective: To understand the consciousness of the cancer early treatment and its demographic and socioeconomic factors. Methods: A cross-sectional survey was conducted in 16 provinces covered by the Cancer Screening Program in Urban China (CanSPUC) from 2015 to 2017. A total of 32 257 local residents aged ≥18 years old who could understand the investigation procedure were included in the study by using the cluster sampling method and convenient sampling method. All local residents were categorized into four groups, which contained 15 524 community residents, 8 016 cancer risk assessment/screening population, 2 289 cancer patients and 6 428 occupational population, respectively. The questionnaire collected personal information, the consciousness of the cancer early treatment and relevant factors. The Chi square test was used to compare the difference between the consciousness of the cancer early treatment and relevant factors among the four groups. The logistic regression model was used to analyze the influencing factors related to the consciousness of the cancer early treatment. Results: With the assumption of being diagnosed as precancer or cancer, 89.97% of community residents, 91.84% of cancer risk assessment/screening population, 93.00% of cancer patients and 91.52% of occupational population would accept active treatments (P<0.001). If the immediate family members were diagnosed as precancer or cancer, people who would encourage their family members to receive early treatment in the four groups accounted for 91.96%, 91.94%, 92.44% and 91.55%, respectively (P<0.001). The company employees, annual household income with 40 000 yuan and more and other three groups had a relatively better consciousness of the cancer early treatment (P<0.05). Male, widowed, unemployed and from the central and western regions had a relatively worse consciousness of the cancer early treatment (P<0.05). Conclusion: Residents in urban China participants had a good consciousness of the cancer early treatment. The marital status, occupation, annual household income and residential regions were major factors related to the consciousness of the cancer early treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: População Urbana / Conhecimentos, Atitudes e Prática em Saúde / Tempo para o Tratamento / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: População Urbana / Conhecimentos, Atitudes e Prática em Saúde / Tempo para o Tratamento / Neoplasias Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China